P070 Long-term efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): results from the TOMORROW trial and its open-label extension | Zendy

AI Assistant Blog Pricing

P070 <break /> Long-term efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): results from the TOMORROW trial and its open-label extension

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.